AzTrials
AzTrials

Intimate Partner ViolencePhase 2NCT00539812

Brief Intervention to Reduce Drinking and Intimate Partner Violence in Women

A Phase 2 study of Intimate Partner Violence and Substance Use, run by The University of Tennessee, Knoxville at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to examine whether adding a brief alcohol treatment to standard violence intervention programs for women will result in reduced drinking, reduced partner violence perpetration, and reduced partner violence victimization. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Intimate Partner Violence, Substance Use
Could I receive a placebo?
No, everyone receives an active treatment
How many people
225 participants
Where
1 siteUnited States
Study dates
May 2007to May 2013
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Hazardous drinking
  • Participation in a batterer intervention program

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Gregory L Stuart, Ph.D. contact

865-974-3358

gstuart@utk.edu

United States1 site, 1 recruiting
  • Butler Hospital & University of Tennessee-Knoxville

    Providence, Rhode Island, 02906

    Gregory L Stuart, PhD

    Recruiting

Other trials in United States

About this study

The purpose of this study is to examine whether adding a brief alcohol treatment to standard violence intervention programs for women will result in reduced drinking, reduced partner violence perpetration, and reduced partner violence victimization. We hypothesize that, relative to standard care, women receiving the additional brief alcohol intervention will have better alcohol use and partner violence outcomes.

Being tested
Standard Care, Brief Alcohol Intervention combined with standard care
Keywords
Intimate partner violence, alcohol use, substance use
Medical subject headings
Substance-Related Disorders, Alcohol Drinking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard CareBehavioural

    Standard 40 hour state mandated batterer intervention program

  • Brief Alcohol Intervention combined with standard careBehavioural

    Brief alcohol intervention combined with standard 40 hour state mandated batterer intervention program

Study groups in NCT00539812
Study groupRoleWhat they receive
1OtherStandard Care only (standard batterer intervention program)
Receives: Behavioral: Standard Care
2OtherBrief alcohol intervention combined with standard care
Receives: Behavioral: Brief Alcohol Intervention combined with standard care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Substance use and intimate partner violence

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2007 (estimated)
  2. Study startMay 2007
  3. Primary completionMay 2013 (estimated)
  4. Study completionMay 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
225 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00539812
Sponsor's protocol ID
NIAAA-STU_016315__0111-001
Other IDs
R01AA016315
Status last verified
Dec 2012
First submitted
24 Sep 2007
Last updated
18 Dec 2012
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study of Intimate Partner Violence and Substance Use, run by The University of Tennessee, Knoxville at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Dec 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gregory L Stuart, Ph.D. (865-974-3358, gstuart@utk.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Substance use and intimate partner violence (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in